Report cover image

Global Artificial Intelligence Medical Software Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 06, 2026
Length 197 Pages
SKU # APRC20776420

Description

The global Artificial Intelligence Medical Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Artificial Intelligence Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence Medical Software include 2bPrecise, CliniSys, Fabric Genomics, Flatiron Health, Foundation Medicine, Gene42, Human Longevity, IBM and Koninklijke Philips, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Artificial Intelligence Medical Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence Medical Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence Medical Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence Medical Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence Medical Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence Medical Software revenue, projected growth trends, production technology, application and end-user industry.


Artificial Intelligence Medical Software Segment by Company

2bPrecise
CliniSys
Fabric Genomics
Flatiron Health
Foundation Medicine
Gene42
Human Longevity
IBM
Koninklijke Philips
LifeOmic Health
Pierian
SOPHiA GENETICS
Syapse
Tempus
Translational Software

Artificial Intelligence Medical Software Segment by Type

Image Recognition
Natural Language Processing
Others

Artificial Intelligence Medical Software Segment by Application

Drug Discovery
Precision Medicine
Others

Artificial Intelligence Medical Software Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Medical Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Medical Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Medical Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Artificial Intelligence Medical Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Artificial Intelligence Medical Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence Medical Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Artificial Intelligence Medical Software Market by Type
1.2.1 Global Artificial Intelligence Medical Software Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Image Recognition
1.2.3 Natural Language Processing
1.2.4 Others
1.3 Artificial Intelligence Medical Software Market by Application
1.3.1 Global Artificial Intelligence Medical Software Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Drug Discovery
1.3.3 Precision Medicine
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Artificial Intelligence Medical Software Market Dynamics
2.1 Artificial Intelligence Medical Software Industry Trends
2.2 Artificial Intelligence Medical Software Industry Drivers
2.3 Artificial Intelligence Medical Software Industry Opportunities and Challenges
2.4 Artificial Intelligence Medical Software Industry Restraints
3 Global Growth Perspective
3.1 Global Artificial Intelligence Medical Software Market Perspective (2021-2032)
3.2 Global Artificial Intelligence Medical Software Growth Trends by Region
3.2.1 Global Artificial Intelligence Medical Software Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Artificial Intelligence Medical Software Market Size by Region (2021-2026)
3.2.3 Global Artificial Intelligence Medical Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Artificial Intelligence Medical Software Revenue by Players
4.1.1 Global Artificial Intelligence Medical Software Revenue by Players (2021-2026)
4.1.2 Global Artificial Intelligence Medical Software Revenue Market Share by Players (2021-2026)
4.1.3 Global Artificial Intelligence Medical Software Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Artificial Intelligence Medical Software Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Artificial Intelligence Medical Software Key Players Headquarters & Area Served
4.4 Global Artificial Intelligence Medical Software Players, Product Type & Application
4.5 Global Artificial Intelligence Medical Software Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Artificial Intelligence Medical Software Market CR5 and HHI
4.6.3 2025 Artificial Intelligence Medical Software Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence Medical Software Market Size by Type
5.1 Global Artificial Intelligence Medical Software Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Artificial Intelligence Medical Software Revenue by Type (2021-2032)
5.3 Global Artificial Intelligence Medical Software Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence Medical Software Market Size by Application
6.1 Global Artificial Intelligence Medical Software Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Artificial Intelligence Medical Software Revenue by Application (2021-2032)
6.3 Global Artificial Intelligence Medical Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 2bPrecise
7.1.1 2bPrecise Company Information
7.1.2 2bPrecise Business Overview
7.1.3 2bPrecise Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.1.4 2bPrecise Artificial Intelligence Medical Software Product Portfolio
7.1.5 2bPrecise Recent Developments
7.2 CliniSys
7.2.1 CliniSys Company Information
7.2.2 CliniSys Business Overview
7.2.3 CliniSys Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.2.4 CliniSys Artificial Intelligence Medical Software Product Portfolio
7.2.5 CliniSys Recent Developments
7.3 Fabric Genomics
7.3.1 Fabric Genomics Company Information
7.3.2 Fabric Genomics Business Overview
7.3.3 Fabric Genomics Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.3.4 Fabric Genomics Artificial Intelligence Medical Software Product Portfolio
7.3.5 Fabric Genomics Recent Developments
7.4 Flatiron Health
7.4.1 Flatiron Health Company Information
7.4.2 Flatiron Health Business Overview
7.4.3 Flatiron Health Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.4.4 Flatiron Health Artificial Intelligence Medical Software Product Portfolio
7.4.5 Flatiron Health Recent Developments
7.5 Foundation Medicine
7.5.1 Foundation Medicine Company Information
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.5.4 Foundation Medicine Artificial Intelligence Medical Software Product Portfolio
7.5.5 Foundation Medicine Recent Developments
7.6 Gene42
7.6.1 Gene42 Company Information
7.6.2 Gene42 Business Overview
7.6.3 Gene42 Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.6.4 Gene42 Artificial Intelligence Medical Software Product Portfolio
7.6.5 Gene42 Recent Developments
7.7 Human Longevity
7.7.1 Human Longevity Company Information
7.7.2 Human Longevity Business Overview
7.7.3 Human Longevity Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.7.4 Human Longevity Artificial Intelligence Medical Software Product Portfolio
7.7.5 Human Longevity Recent Developments
7.8 IBM
7.8.1 IBM Company Information
7.8.2 IBM Business Overview
7.8.3 IBM Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.8.4 IBM Artificial Intelligence Medical Software Product Portfolio
7.8.5 IBM Recent Developments
7.9 Koninklijke Philips
7.9.1 Koninklijke Philips Company Information
7.9.2 Koninklijke Philips Business Overview
7.9.3 Koninklijke Philips Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.9.4 Koninklijke Philips Artificial Intelligence Medical Software Product Portfolio
7.9.5 Koninklijke Philips Recent Developments
7.10 LifeOmic Health
7.10.1 LifeOmic Health Company Information
7.10.2 LifeOmic Health Business Overview
7.10.3 LifeOmic Health Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.10.4 LifeOmic Health Artificial Intelligence Medical Software Product Portfolio
7.10.5 LifeOmic Health Recent Developments
7.11 Pierian
7.11.1 Pierian Company Information
7.11.2 Pierian Business Overview
7.11.3 Pierian Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.11.4 Pierian Artificial Intelligence Medical Software Product Portfolio
7.11.5 Pierian Recent Developments
7.12 SOPHiA GENETICS
7.12.1 SOPHiA GENETICS Company Information
7.12.2 SOPHiA GENETICS Business Overview
7.12.3 SOPHiA GENETICS Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.12.4 SOPHiA GENETICS Artificial Intelligence Medical Software Product Portfolio
7.12.5 SOPHiA GENETICS Recent Developments
7.13 Syapse
7.13.1 Syapse Company Information
7.13.2 Syapse Business Overview
7.13.3 Syapse Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.13.4 Syapse Artificial Intelligence Medical Software Product Portfolio
7.13.5 Syapse Recent Developments
7.14 Tempus
7.14.1 Tempus Company Information
7.14.2 Tempus Business Overview
7.14.3 Tempus Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.14.4 Tempus Artificial Intelligence Medical Software Product Portfolio
7.14.5 Tempus Recent Developments
7.15 Translational Software
7.15.1 Translational Software Company Information
7.15.2 Translational Software Business Overview
7.15.3 Translational Software Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
7.15.4 Translational Software Artificial Intelligence Medical Software Product Portfolio
7.15.5 Translational Software Recent Developments
8 North America
8.1 North America Artificial Intelligence Medical Software Revenue (2021-2032)
8.2 North America Artificial Intelligence Medical Software Revenue by Type (2021-2032)
8.2.1 North America Artificial Intelligence Medical Software Revenue by Type (2021-2026)
8.2.2 North America Artificial Intelligence Medical Software Revenue by Type (2027-2032)
8.3 North America Artificial Intelligence Medical Software Revenue Share by Type (2021-2032)
8.4 North America Artificial Intelligence Medical Software Revenue by Application (2021-2032)
8.4.1 North America Artificial Intelligence Medical Software Revenue by Application (2021-2026)
8.4.2 North America Artificial Intelligence Medical Software Revenue by Application (2027-2032)
8.5 North America Artificial Intelligence Medical Software Revenue Share by Application (2021-2032)
8.6 North America Artificial Intelligence Medical Software Revenue by Country
8.6.1 North America Artificial Intelligence Medical Software Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Artificial Intelligence Medical Software Revenue by Country (2021-2026)
8.6.3 North America Artificial Intelligence Medical Software Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Artificial Intelligence Medical Software Revenue (2021-2032)
9.2 Europe Artificial Intelligence Medical Software Revenue by Type (2021-2032)
9.2.1 Europe Artificial Intelligence Medical Software Revenue by Type (2021-2026)
9.2.2 Europe Artificial Intelligence Medical Software Revenue by Type (2027-2032)
9.3 Europe Artificial Intelligence Medical Software Revenue Share by Type (2021-2032)
9.4 Europe Artificial Intelligence Medical Software Revenue by Application (2021-2032)
9.4.1 Europe Artificial Intelligence Medical Software Revenue by Application (2021-2026)
9.4.2 Europe Artificial Intelligence Medical Software Revenue by Application (2027-2032)
9.5 Europe Artificial Intelligence Medical Software Revenue Share by Application (2021-2032)
9.6 Europe Artificial Intelligence Medical Software Revenue by Country
9.6.1 Europe Artificial Intelligence Medical Software Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Artificial Intelligence Medical Software Revenue by Country (2021-2026)
9.6.3 Europe Artificial Intelligence Medical Software Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Artificial Intelligence Medical Software Revenue (2021-2032)
10.2 China Artificial Intelligence Medical Software Revenue by Type (2021-2032)
10.2.1 China Artificial Intelligence Medical Software Revenue by Type (2021-2026)
10.2.2 China Artificial Intelligence Medical Software Revenue by Type (2027-2032)
10.3 China Artificial Intelligence Medical Software Revenue Share by Type (2021-2032)
10.4 China Artificial Intelligence Medical Software Revenue by Application (2021-2032)
10.4.1 China Artificial Intelligence Medical Software Revenue by Application (2021-2026)
10.4.2 China Artificial Intelligence Medical Software Revenue by Application (2027-2032)
10.5 China Artificial Intelligence Medical Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Artificial Intelligence Medical Software Revenue (2021-2032)
11.2 Asia Artificial Intelligence Medical Software Revenue by Type (2021-2032)
11.2.1 Asia Artificial Intelligence Medical Software Revenue by Type (2021-2026)
11.2.2 Asia Artificial Intelligence Medical Software Revenue by Type (2027-2032)
11.3 Asia Artificial Intelligence Medical Software Revenue Share by Type (2021-2032)
11.4 Asia Artificial Intelligence Medical Software Revenue by Application (2021-2032)
11.4.1 Asia Artificial Intelligence Medical Software Revenue by Application (2021-2026)
11.4.2 Asia Artificial Intelligence Medical Software Revenue by Application (2027-2032)
11.5 Asia Artificial Intelligence Medical Software Revenue Share by Application (2021-2032)
11.6 Asia Artificial Intelligence Medical Software Revenue by Country
11.6.1 Asia Artificial Intelligence Medical Software Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Artificial Intelligence Medical Software Revenue by Country (2021-2026)
11.6.3 Asia Artificial Intelligence Medical Software Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Artificial Intelligence Medical Software Revenue (2021-2032)
12.2 SAMEA Artificial Intelligence Medical Software Revenue by Type (2021-2032)
12.2.1 SAMEA Artificial Intelligence Medical Software Revenue by Type (2021-2026)
12.2.2 SAMEA Artificial Intelligence Medical Software Revenue by Type (2027-2032)
12.3 SAMEA Artificial Intelligence Medical Software Revenue Share by Type (2021-2032)
12.4 SAMEA Artificial Intelligence Medical Software Revenue by Application (2021-2032)
12.4.1 SAMEA Artificial Intelligence Medical Software Revenue by Application (2021-2026)
12.4.2 SAMEA Artificial Intelligence Medical Software Revenue by Application (2027-2032)
12.5 SAMEA Artificial Intelligence Medical Software Revenue Share by Application (2021-2032)
12.6 SAMEA Artificial Intelligence Medical Software Revenue by Country
12.6.1 SAMEA Artificial Intelligence Medical Software Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Artificial Intelligence Medical Software Revenue by Country (2021-2026)
12.6.3 SAMEA Artificial Intelligence Medical Software Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.